Home >> Tag Archives: Resolution Bioscience—

Tag Archives: Resolution Bioscience—

CLIA-certified liquid biopsy for NSCLC launched

May 29, 2015—Resolution Bioscience recently announced the successful results from their CLIA validation of ctDx ALK, a blood-based liquid biopsy for an ALK-gene fusion driver mutation found in non-small cell lung carcinoma. Researchers or clinicians can use the test to guide patients to personalized therapies and direct them into clinical trials with a standard blood sample. The Resolution Bio platform ...

Read More »